BioCentury
ARTICLE | Emerging Company Profile

Neurimmune: Reversing forward

December 3, 2007 8:00 AM UTC

More than 200 years ago, Edward Jenner invented the practice of vaccination based on an observation that people who'd been infected with cowpox were immune to smallpox, and the subsequent finding that immunity could be transferred by inoculating people with fluids from cowpox sufferers.

The discovery also gave birth to the practice of reverse translational medicine, in which new therapeutics are developed based on the study of people who are able to combat disease on their own. Neurimmune Therapeutics AG is taking that approach to finding a treatment for Alzheimer's disease (AD)...